Goldman Sachs’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-12,650
| Closed | -$84K | – | 4400 |
|
|
2019
Q2 | $84K | Buy |
+12,650
| New | +$84K | ﹤0.01% | 4027 |
|
|
2018
Q4 | – | Sell |
-2,125
| Closed | -$42K | – | 4346 |
|
|
2018
Q3 | $42K | Buy |
+2,125
| New | +$42K | ﹤0.01% | 4032 |
|
|
2018
Q2 | – | Sell |
-3,551
| Closed | -$131K | – | 4398 |
|
|
2018
Q1 | $131K | Sell |
3,551
-2,655
| -43% | -$97.9K | ﹤0.01% | 3966 |
|
|
2017
Q4 | $490K | Buy |
+6,206
| New | +$490K | ﹤0.01% | 3467 |
|